Related Experiment Video
Updated: Jul 4, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[Asthma bronchiale--medical treatment]
Steurer Claudia Stey1, Erich W Russi
1Klinik für Pneumologie, Departement für Innere Medizin, Universitätsspital Zürich.
Therapeutische Umschau. Revue Therapeutique
|June 17, 2008
Summary
Asthma management has shifted focus from severity to control, emphasizing regular assessment and tailored pharmacotherapy. Achieving and maintaining asthma control requires a comprehensive approach including diagnosis, treatment, follow-up, and self-management education.
Area of Science:
- Pulmonology and Respiratory Medicine
- Clinical Pharmacology
Context:
- Asthma is a prevalent chronic inflammatory airway disease with significant health and economic burdens.
- Previous asthma guidelines classified severity by symptom levels and airflow limitation.
- Newer Global Initiative for Asthma (GINA) guidelines prioritize asthma control over severity categorization.
Purpose:
- To provide an overview of current pharmacotherapy strategies for adult asthma patients.
- To highlight the critical importance of achieving and maintaining asthma control.
- To discuss the components of long-term asthma control management.
Summary:
- Asthma management has evolved from severity-based to control-based approaches.
- The new GINA guidelines define three asthma control categories: controlled, partly controlled, and uncontrolled.
- Effective asthma control involves diagnosis, pharmacotherapy, regular follow-up, and patient self-management education.
Impact:
- This overview emphasizes a shift towards a more dynamic and patient-centered approach to asthma management.
- Focusing on asthma control can lead to improved patient outcomes and reduced healthcare costs.
- Understanding pharmacotherapy's role is crucial for clinicians aiming to achieve and sustain asthma control in adult patients.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...